Cargando…
Immunotherapy for Epstein-Barr Virus-Related Lymphomas
Latent EBV infection is associated with several malignancies, including EBV post-transplant lymphoproliferative disorders (LPD), Hodgkin and non-Hodgkin lymphomas, nasopharyngeal carcinoma and Burkitt lymphoma. The range of expression of latent EBV antigens varies in these tumors, which influences h...
Autores principales: | Kennedy-Nasser, Alana A., Bollard, Catherine M., Heslop, Helen E. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Università Cattolica del Sacro Cuore
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3033176/ https://www.ncbi.nlm.nih.gov/pubmed/21416001 http://dx.doi.org/10.4084/MJHID.2009.010 |
Ejemplares similares
-
Cytotoxic T Lymphocyte Therapy for Epstein-Barr Virus(+) Hodgkin's Disease
por: Bollard, Catherine M., et al.
Publicado: (2004) -
Epstein-Barr virus and Burkitt lymphoma
por: Rowe, Martin, et al.
Publicado: (2014) -
Epstein-Barr virus and the origin of Hodgkin lymphoma
por: Vockerodt, Martina, et al.
Publicado: (2014) -
Clinical and Therapeutic Implications of Epstein–Barr Virus in HIV-Related Lymphomas
por: Verdu-Bou, Miriam, et al.
Publicado: (2021) -
Epstein–Barr virus-associated lymphomas
por: Shannon-Lowe, Claire, et al.
Publicado: (2017)